These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24712326)

  • 1. Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models.
    Festuccia C; Gravina GL; Mancini A; Muzi P; Cesare ED; Kirk R; Smith M; Hughes S; Gibson R; Lian LY; Ricevuto E; Carnell AJ
    Anticancer Agents Med Chem; 2014; 14(7):1031-41. PubMed ID: 24712326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 2-arylthiopropanoyl-CoA inhibitors of α-methylacyl-CoA racemase 1A (AMACR; P504S) as potential anti-prostate cancer agents.
    Yevglevskis M; Nathubhai A; Wadda K; Lee GL; Al-Rawi S; Jiao T; Mitchell PJ; James TD; Threadgill MD; Woodman TJ; Lloyd MD
    Bioorg Chem; 2019 Nov; 92():103263. PubMed ID: 31536953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
    Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB
    Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
    Kunju LP; Chinnaiyan AM; Shah RB
    Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
    Carnell AJ; Kirk R; Smith M; McKenna S; Lian LY; Gibson R
    ChemMedChem; 2013 Oct; 8(10):1643-7. PubMed ID: 23929631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2201-2210. PubMed ID: 28741117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
    Zhou M; Jiang Z; Epstein JI
    Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.
    Mobley JA; Leav I; Zielie P; Wotkowitz C; Evans J; Lam YW; L'Esperance BS; Jiang Z; Ho SM
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):775-83. PubMed ID: 12917210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S).
    Wilson BA; Wang H; Nacev BA; Mease RC; Liu JO; Pomper MG; Isaacs WB
    Mol Cancer Ther; 2011 May; 10(5):825-38. PubMed ID: 21441411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.
    Wu CL; Yang XJ; Tretiakova M; Patton KT; Halpern EF; Woda BA; Young RH; Jiang Z
    Hum Pathol; 2004 Aug; 35(8):1008-13. PubMed ID: 15297968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel small-molecule inhibitors of α-methylacyl-CoA racemase (AMACR; P504S) and structure-activity relationships.
    Petrova YD; Wadda K; Nathubhai A; Yevglevskis M; Mitchell PJ; James TD; Threadgill MD; Woodman TJ; Lloyd MD
    Bioorg Chem; 2019 Nov; 92():103264. PubMed ID: 31536955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
    Kumar-Sinha C; Shah RB; Laxman B; Tomlins SA; Harwood J; Schmitz W; Conzelmann E; Sanda MG; Wei JT; Rubin MA; Chinnaiyan AM
    Am J Pathol; 2004 Mar; 164(3):787-93. PubMed ID: 14982833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors.
    Morgenroth A; Urusova EA; Dinger C; Al-Momani E; Kull T; Glatting G; Frauendorf H; Jahn O; Mottaghy FM; Reske SN; Zlatopolskiy BD
    Chemistry; 2011 Aug; 17(36):10144-50. PubMed ID: 21812041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
    Kaić G; Tomasović-Loncarić C
    Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer.
    Honma I; Torigoe T; Hirohashi Y; Kitamura H; Sato E; Masumori N; Tamura Y; Tsukamoto T; Sato N
    J Transl Med; 2009 Dec; 7():103. PubMed ID: 20003233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
    Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.
    Kuefer R; Varambally S; Zhou M; Lucas PC; Loeffler M; Wolter H; Mattfeldt T; Hautmann RE; Gschwend JE; Barrette TR; Dunn RL; Chinnaiyan AM; Rubin MA
    Am J Pathol; 2002 Sep; 161(3):841-8. PubMed ID: 12213712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression.
    Takahara K; Azuma H; Sakamoto T; Kiyama S; Inamoto T; Ibuki N; Nishida T; Nomi H; Ubai T; Segawa N; Katsuoka Y
    Anticancer Res; 2009 Jul; 29(7):2497-505. PubMed ID: 19596919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
    Maria McCrohan A; Morrissey C; O'Keane C; Mulligan N; Watson C; Smith J; Fitzpatrick JM; Watson RW
    Cancer; 2006 Jun; 106(12):2743-52. PubMed ID: 16703599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.